Earlier, insulin for diabetic patients was extracted from the pancreas of cattle and pigs. However, it had several drawbacks:
\begin{enumerate}
\item Immunological reactions: Animal insulin differed slightly in amino acid sequence from human insulin, sometimes causing allergic reactions or immune responses in patients.
\item Risk of infections: There was a possibility of transmitting animal-borne pathogens and contaminants through animal-derived insulin.
\item Limited supply and cost: Large numbers of animals had to be slaughtered to obtain small amounts of insulin, making the process costly and unsustainable.
\end{enumerate}
Conclusion.
These drawbacks were overcome by developing recombinant human insulin using genetically engineered E. coli, which is safer, cheaper, and identical to natural human insulin.